During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

A research team led by Professor Won Jong Kim from the Department of Chemistry at POSTECH, in collaboration with the Korea ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) ...

The mRNA vaccine against avian influenza presents several advantages and disadvantages: Advantages: Rapid Development and Production; Non-Infectious Nature; Strong Immune Response; Adaptability to ...

Researchers have found a new way to reduce the effects of pre-eclampsia using mRNA-lipid nanoparticle therapies.

"Everything injected into the bloodstream is eventually ends up in the liver — that's just how our anatomy works," Professor ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...